Details for New Drug Application (NDA): 219406
✉ Email this page to a colleague
NDA 219406 describes CLOMIPHENE CITRATE, which is a drug marketed by Accord Hlthcare, Appco, Cosette, Novitium Pharma, and Rubicon, and is included in five NDAs. It is available from eight suppliers. Additional details are available on the CLOMIPHENE CITRATE profile page.
The generic ingredient in CLOMIPHENE CITRATE is clomiphene citrate. There are sixteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
The generic ingredient in CLOMIPHENE CITRATE is clomiphene citrate. There are sixteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
Summary for 219406
| Tradename: | CLOMIPHENE CITRATE |
| Applicant: | Accord Hlthcare |
| Ingredient: | clomiphene citrate |
| Patents: | 0 |
Pharmacology for NDA: 219406
| Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 219406
Suppliers and Packaging for NDA: 219406
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOMIPHENE CITRATE | clomiphene citrate | TABLET;ORAL | 219406 | ANDA | Accord Healthcare Inc. | 16729-723 | 16729-723-51 | 1 BLISTER PACK in 1 CARTON (16729-723-51) / 30 TABLET in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Oct 3, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
